14 September 2020
Hogan Lovells advises Valneva on its COVID-19 vaccine partnership with the UK Government
Advising firms
Deal team
8 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Peter Watts Lead | Hogan Lovells Cadwalader | Partner | corporate | London |
| Jane Summerfield Lead | Hogan Lovells Cadwalader | Partner | Not stated | London |
| Stephen Reese Lead | Clifford Chance | Partner | Not stated | Not stated |
| Caitlin Weeks | Hogan Lovells Cadwalader | Senior associate | Not stated | Not stated |
| Nagham Al-Turaihi | Hogan Lovells Cadwalader | Associate | Not stated | Not stated |
| Jean-Marc Franceschi | Hogan Lovells Cadwalader | Partner | corporate | Paris |
| Katie McConnell | Hogan Lovells Cadwalader | Partner | IP | London |
| Anishiya Abrol | Hogan Lovells Cadwalader | Counsel | IP | Washington DC |
5 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- EUR 470m (around €470 million)
- What the figure measures
- Total transaction value
- Client
- ValnevaOther
- Counterparties
- UK Government (Other)